[Present status of oral treatment of diabetes.]

[Present status of oral treatment of diabetes.] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

[Present status of oral treatment of diabetes.] Abstract Text:

F BERTRAM,

[Present status of oral treatment of diabetes.] Publishing Authors By Initials

F BERTRAM,

For similar organic chemicals: urea research abstracts see: organic chemicals: urea research

PUBMED ID PMID:

MEDLINE DATE:

[Present status of oral treatment of diabetes.] Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Revista ibérica de endocrinología

VOLUME: 4

Page Numbers: 7-14

Journal Abbreviation:

ISSN: 0034-9615

DAY: 24

MONTH: 01

YEAR: 2008

[Present status of oral treatment of diabetes.] Information

Number of References:

LANGUAGE: spa

NlmUniqueID: 404307

[Present status of oral treatment of diabetes.] Keywords Mesh Terms:

KEYWORDS: Urea

MESH TERMS: analogs & derivatives

Chemical & Substance for Abstract: [Present status of oral treatment of diabetes.] Information

Substance Name: sulfanilamide

Registry Number: 63-74-1

Grant and Affiliation Information for [Present status of oral treatment of diabetes.]

AFFILIATION:

Country: Not Available

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Rev Iber Endocrinol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Present status of oral treatment of diabetes Related Publications

• A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis.
• A novel flow reactor for studying reactions on liquid surfaces coated by organic monolayers: methods, validation, and initial results.
• A-type k(+) current can act as a trigger for bursting in the absence of a slow variable.
• Alterations in GABAA Receptor Mediated Inhibition in Adjacent Dorsal Midline Thalamic Nuclei in a Rat Model of Chronic Limbic Epilepsy.
• An unusual arterial waveform.
• BMPs and BMP receptors in mouse metanephric development: in vivo and in vitro studies.
• Chemoprophylaxis of experimental filariasis in the cotton-rat.
• Crystallization of aqueous ammonium sulfate particles internally mixed with soot and kaolinite: crystallization relative humidities and nucleation rates.
• DISCUSSION OF THE TABULAR DATA FROM THE TEN-YEAR MARSHALL, TEXAS DENTAL-FLUORIDATION STUDY.
• Electrical velocimetry for measuring cardiac output in children with congenital heart disease.
• Experiences and constructions of art: a narrative-discourse analysis.
• Glomerular volume and clinicopathologic features related to disease severity in renal biopsies of African Americans and whites in the southeastern United States.
• Identification of allyl esters in garlic cheese.
• Low dose of dopamine may stimulate prolactin secretion by increasing fast potassium currents.
• Managing an emergency department: the effect of patient flow on physician performance.
• Measuring hospital case mix: a primer.
• Metabolism of nitrosamines in vivo. 3. On the methylation of nucleic acids by aliphatic Di-n-alkyl-nitrosamines in vivo resueting from heta-oxidation: the formation of 7-methylguanine after application of 2-oxo-propyl-propyl-nitrosamine and methyl-propyl-
• New perspectives on brachiation mechanics.
• PIPATH: an optimized algorithm for generating alpha-helical structures from PISEMA data.
• Physician reimbursement and the quantity and quality of health care services.
• Radiotherapy in the Royal Navy.
• Superficial digital flexor tendon lesions in racehorses as a sequela to muscle fatigue: A preliminary study.
• The percentage of school enterers having received immunization in the borough of Etobicoke in 1972.
• The role of interword spacing in reading Japanese: an eye movement study.
• [Experiences on 1,000 diabetics treated with sulfonylureas (BZ 55 and D 860).]
• [In vitro studies of the causative agent of infectious anemia (CAA) in chickens: multiplication, titration, serum neutralization test and the indirect immunofluorescence test]
• [Oral management of diabetes mellitus with a sulfonyl-urea derivative, BZ 55.]
• [Oral management of diabetes mellitus.]
• [Present status of oral treatment of diabetes.]
• [Pyogenic infections of the skin and skin appendages]